Stellantis N.V. Files 6-K Report

Ticker: STLA · Form: 6-K · Filed: Jan 16, 2025 · CIK: 1605484

Stellantis N.V. 6-K Filing Summary
FieldDetail
CompanyStellantis N.V. (STLA)
Form Type6-K
Filed DateJan 16, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

Related Tickers: STLA

TL;DR

STLA filed a 6-K, nothing major, just a routine update.

AI Summary

Stellantis N.V. filed a Form 6-K on January 16, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its report under the 1934 Securities Exchange Act. Stellantis N.V. was formerly known as Fiat Chrysler Automobiles N.V. and Fiat Investments N.V.

Why It Matters

This filing is a routine report for foreign private issuers, providing an update on the company's regulatory status and historical name changes.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.

Key Numbers

  • 20250116 — Filing Date (Date the 6-K was filed with the SEC)

Key Players & Entities

  • Stellantis N.V. (company) — Filer of the report
  • Fiat Chrysler Automobiles N.V. (company) — Former name of Stellantis N.V.
  • Fiat Investments N.V. (company) — Former name of Stellantis N.V.
  • 001-36675 (dollar_amount) — SEC File Number

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to submit information that the company has made or is required to make public in its home country.

What is Stellantis N.V.'s SEC File Number?

Stellantis N.V.'s SEC File Number is 001-36675.

When was Stellantis N.V. formerly known as Fiat Chrysler Automobiles N.V.?

The date of the name change from Fiat Chrysler Automobiles N.V. to Stellantis N.V. was October 14, 2014.

What is the principal executive office address for Stellantis N.V.?

The principal executive office address is Taurusavenue 1, 2132LS, Hoofddorp, The Netherlands.

Does Stellantis N.V. file annual reports under Form 20-F or Form 40-F?

Stellantis N.V. files annual reports under cover of Form 20-F.

Filing Stats: 221 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2025-01-16 14:04:26

Filing Documents

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 6-K _______________________________ REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File No. 001-36675 _______________________________ STELLANTIS N.V. (Translation of Registrant's Name Into English) _______________________________ Taurusavenue 1 2132LS, Hoofddorp The Netherlands Tel. No. +31 237001511 (Address of Principal Executive Offices) _______________________________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1) o Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7) o The following exhibit is furnished herewith Exhibit 99.1 Press release issued by Stellantis N.V. dated January 16, 2025. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date January 16, 2025 STELLANTIS N.V. By s Giorgio Fossati Name Giorgio Fossati Title General Counsel Index of Exhibits Exhibit Number Description of Exhibit 99.1 Press release issued by Stellantis N.V. dated January 16, 2025.

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.